Proteus Digital Health’s Ingestible Sensors Approved by FDA

by Kathy Jones on  August 2, 2012 at 6:54 PM Medical Gadgets   - G J E 4
In a major step bringing cutting edge technology to patient care, the US Food and Drug Administration has confirmed that it has approved Proteus Digital Health's ingestible sensors that transmit data, such as whether patients are taking pills regularly and their vital signs, to medical professionals.
 Proteus Digital Health’s Ingestible Sensors Approved by FDA
Proteus Digital Health’s Ingestible Sensors Approved by FDA

The sensor, sold under the brand name Ingestion Event Marker (IEM), has already been approved in Europe and can be ingested by placing it in a capsule. IEM draws its power from stomach fluid and sends data to a patch attached to the user's stomach.

The data includes whether the user is taking medicine on time and vital signs such as heart rate, body activity and position. This data is then sent to the user's medical caregiver through a mobile phone app.

Stating that the company is delighted with the approval, Proteus Digital Health co-founder and CMO Dr George Savage said, "We are thrilled to have achieved this important milestone to market our ingestible sensor in the United States now, as well as in Europe. We are very much looking forward to bringing the benefits of our ingestible sensor to the American public in the form of innovative product offerings."

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like